15th January 2025, Wednesday

TechPharus

Latest Posts

HealthTech News

  • Pediatrics study examines the diagnostic potential of microbial cell-free DNA testing
    on January 15, 2025 at 9:52 pm

    Ear, nose, and throat (ENT) infections are one of the most common reasons for prescribing antibiotics to children. Although some ENT infections can be simple to identify and diagnose, others are more severe and require immediate attention and care.

  • Combining ctDNA and genomic profiling predicts cancer relapse and treatment response
    on January 15, 2025 at 9:33 pm

    Researchers from Iwate Medical University and Tohoku University have revealed that it is possible to predict cancer relapse and treatment response by measuring circulating tumor DNA (ctDNA), in tandem with data from comprehensive genomic profiling (CGP). Their study is published in the journal Cancer Science.

  • Study explores how Tourette syndrome differs by sex
    on January 15, 2025 at 9:28 pm

    Tourette syndrome is currently diagnosed about three times more frequently in males than in females. A new study finds that female individuals are less likely to be diagnosed with the syndrome, take longer to receive a diagnosis and are older when they are diagnosed than male individuals. The study is published in Neurology.

  • Blood test discovery offers hope for easier asthma diagnosis and care
    on January 15, 2025 at 9:28 pm

    Scientists at Rutgers Health have discovered that a simple blood test could diagnose asthma and determine its severity, a breakthrough that could transform how the disease is identified and monitored.

  • New mechanism that shields persister tumor cells from immune system identified
    on January 15, 2025 at 9:28 pm

    Cancer therapies do not always succeed in eliminating tumor cells. Some of these cells enter a state of senescence—a latent, non-dividing state that is generally irreversible. Others, however, enter a state known as “persistence,” where dormancy is temporary and reversible. This state allows the cells to begin growing again after the treatment has ended, leading to cancer recurrence.